Gonadal function in aging rats and its relation to pituitary and mammary pathology

Abstract

In the female rat, aging is characterized by a high incidence of prolactin (Prl)-secreting pituitary adenomas and mammary tumors. In contrast to this, old males show only a moderate to low incidence of pituitary and mammary pathology. Since gonadal steroids and Prl are thought to be key factors in the genesis of the above neoplastic pathologies, it was of interest to compare the serum levels of progesterone (P), estradiol (E 2), testosterone (T) and Prl with the incidence of pituitary and mammary tumors in aging male and female rats. Young (3–4-month; YF), old (25-month; OF) and senescent (33–35-month; SF) female and young (3–4-month; YM) and old (24–26-month; OM) male Sprague—Dawley rats were killed by decapitation and their pituitaries weighed. Serum sex steroids and Prl were measured by RIA. The average life span of females but not males was markedly extended by systematic removal of mammary tumors. Females showed a rising incidence of mammary tumors after 14 months of age. In males, this pathology which began to appear at 16 months, had a much lower incidence than in females at all ages. Serum levels of E 2 were ( x ± S.E.M.) 22.0 ± 1.6; 18.9 ± 0.8; 32.9 ± 2.5; 37.3 ± 2.0 and 32.2 ± 3.0 pg/ml for YM, OM, YF, OF and SF, respectively. Serum P was 1.4 ± 0.3; 1.6 ± 0.2; 10.4 ± 2.2; 9.7 ± 3.3 and 6.8 ± 0.8 ng/ml for YM, OM, YF, OF and SF, respectively. Serum T was 1578.9 ± 188.7; 807.6 ± 103.0; 197.5 ± 11.8; 223.7 ± 25.5 and 176.9 ± 20.7 pg/ml for YM, OM, YF, OF and SF, respectively. Finally, serum Prl was 14.9 ± 1.7; 21.9 ± 4.0; 15.9 ± 1.4; 52.4 ± 9.4 and 170.8 ± 31.1 ng/ml for YM, OM, YF, OF and SF, respectively. A strong correlation was found between serum Prl and anterior pituitary weight in OM, OF and SF, but not between serum Prl and sex steroid levels or sex steroid ratios. We conclude that, although the sex-related differences in mammary and pituitary tumor incidence during aging in rats can be partially accounted for by the different serum profiles of Prl and gonadal steroids in each sex, sex-associted differences in target tissue susceptibility should also be considered as an important determinant of the level of tumor incidence.